CAGNONI PABLO J 4

What Happened

• Pablo J. Cagnoni, President and Global Head of R&D at Incyte (INCY), exercised a total of 18,667 derivative awards (options/RSU conversions) on April 17, 2026 and sold 18,667 shares the same day. He paid $1,296,046 to exercise the awards (6,077 shares @ $64.25 = $390,447; 12,590 shares @ $71.93 = $905,599) and received gross proceeds of $1,801,366 from an open-market sale at $96.50 per share. The transactions produced gross proceeds in excess of the exercise cost by approximately $505,320.

Key Details

• Transaction date: April 17, 2026.
• Exercises: 6,077 shares @ $64.25 (cost $390,447); 12,590 shares @ $71.93 (cost $905,599).
• Sale: 18,667 shares sold @ $96.50 = $1,801,366 gross proceeds.
• Report filed Apr 21, 2026 — filed on the second business day after the transaction (appears timely).
• Shares owned after transaction: No net change in beneficially owned shares on that date (exercised 18,667 and sold 18,667).
• Footnotes: F1 notes 257,553 shares issuable under previously reported unvested restricted stock units and performance stock units; F2 and F3 describe multi‑installment vesting schedules for prior option grants (37 installments, 25% after one year, remainder monthly over three years).

Context

• These entries reflect a same-day exercise-and-sale (cashless-style) of derivative awards: options/RSU conversions were exercised and the resulting shares were sold in the open market. The lines showing disposition at $0.00 reflect the conversion of the derivative into shares as part of the exercise/reporting mechanics, not a separate cash sale. This is a routine executive liquidity event and does not by itself indicate company performance or insider sentiment.